Cart
sales@molnova.com
Tebufenozide
CAS No. 112410-23-8
Tebufenozide ( —— )
Catalog No. M23317 CAS No. 112410-23-8
Tebufenozide is a novel nonsteroidal ecdysone agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | In Stock |
|
| 50MG | 58 | In Stock |
|
| 100MG | 87 | In Stock |
|
| 200MG | 129 | In Stock |
|
| 500MG | 214 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTebufenozide
-
NoteResearch use only, not for human use.
-
Brief DescriptionTebufenozide is a novel nonsteroidal ecdysone agonist.
-
DescriptionTebufenozide is a novel nonsteroidal ecdysone agonist. It shows good efficacy and playing an increasingly important role in the control of Lepidopteran pests.
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number112410-23-8
-
Formula Weight352.5
-
Molecular FormulaC22H28N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (354.64 mM; Need ultrasonic)
-
SMILESCCc(cc1)ccc1C(NN(C(C)(C)C)C(c1cc(C)cc(C)c1)=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yun-Sik L , Sung-Eun L , Jino S , et al. Toxicity effects and biomarkers of tebufenozide exposure in Yuukianura szeptyckii (Collembola: Neanuridae)[J]. Environmental Geochemistry & Health, 2018:1-12.
molnova catalog
related products
-
NHWD-870
NHWD-870 is an effective and selective inhibitor of BET family bromodomain only binding to BRD2, BRD3, BRD4 (IC50 = 2.7 nM), and BRDT.
-
K145 hydrochloride
K145 hydrochloride is a selective sphk2 inhibitor with substrate competitiveness and oral activity, with IC50 of 4.3 μM and Ki of 6.4 μM. K145 hydrochloride can induce apoptosis and has strong antitumor activity.
-
CHM-1
CHM-1 is an inducer of apoptosis, and displays potent antitumor ability in human hepatocellular carcinoma by activation of Cdc2 kinase activity. CHM-1 inhibits tubulin polymerization in vitro and in vivo.
